← FDA Drug Approvals (Drugs@FDA)

DIFFERIN

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 1996-05-31

Drug application

FDA Application #

NDA020338

Application type

New Drug Application

Brand name

DIFFERIN

Generic name

Adapalene

Active ingredients

ADAPALENE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

GALDERMA LABS LP

First approval

1996-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown